Publication

Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect?

Jubber, A.
; 
Woodward, J.
; 
Tahir, H.
; 
Moorthy, A.
Abstract
MIDER Authors
Jubber, Ameen
Moorthy, Arumugam
Affiliations
Citations
Altmetric:
Date
2022-08
Type
Article
Subject
Venous thromboembolism
 Inflammatory arthritis
 Janus kinase (JAK) inhibitors
Collections
UHL Rheumatology
Show all metadata
Citation
Jubber, A., Woodward, J., Tahir, H., & Moorthy, A. (2022). Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect?. Expert opinion on drug safety, 21(8), 1005–1007.
Journal / Source Title
DOI
10.1080/14740338.2022.2100343
URI
https://mider.dspace7.openrepository.com/handle/20.500.12904/16053
PMID
Publisher
Publisher’s URL
https://www.tandfonline.com/doi/full/10.1080/14740338.2022.2100343
Publisher’s statement
Note / Copyright